Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion type Assertion NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_head.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion description "[A third group of PTLD is reminiscent of post-GC and pre- terminally differentiated B-cells that show the BCL6(-)/MUM1(+)/CD138(+) phenotype and are morphologically represented by either polymorphic PTLD or DLBCL immunoblastic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_provenance.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion evidence source_evidence_literature NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_provenance.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion SIO_000772 16216037 NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_provenance.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion wasDerivedFrom befree-2016 NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_provenance.
- NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_assertion wasGeneratedBy ECO_0000203 NP517351.RAHLYhvirIvQ-7G5Eq11lDNFmKF2jmdacu5CV4T0dHDL4130_provenance.